Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | RET |
| Variant | M918X |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | RET M918X indicates any Ret missense mutation that results in replacement of the methionine (M) at amino acid 918 by a different amino acid. |
| Associated Drug Resistance | |
| Category Variants Paths |
RET mutant RET M918X |
| Transcript | NM_020975.6 |
| gDNA | chr10:g.43121967_43121969 |
| cDNA | c.2752_2754 |
| Protein | p.M918 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_001406759.1 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020975.5 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_001406744.1 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_001406760.1 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020630.7 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020630 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020975 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020630.5 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_020975.6 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_001406743.1 | chr10:g.43121967_43121969 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| NM_001406771.1 | chr10:g.43128114_43128116 | c.2752_2754 | p.M918 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| RET M918X | medullary thyroid carcinoma | not applicable | N/A | Guideline | Risk Factor | Germline RET M918X mutations result in multiple endocrine neoplasia, type 2B (MEN 2B), which is associated with high risk of developing thyroid medullary carcinoma (NCCN.org). | detail... |